vs

Side-by-side financial comparison of Sphere 3D Corp. (ANY) and Roivant Sciences Ltd. (ROIV). Click either name above to swap in a different company.

Sphere 3D Corp. is the larger business by last-quarter revenue ($2.7M vs $2.0M, roughly 1.4× Roivant Sciences Ltd.). On growth, Sphere 3D Corp. posted the faster year-over-year revenue change (3.1% vs -77.8%). Sphere 3D Corp. produced more free cash flow last quarter ($-23.6M vs $-201.4M). Over the past eight quarters, Sphere 3D Corp.'s revenue compounded faster (-37.4% CAGR vs -73.7%).

Sphere 3D Corp is a global technology company specializing in cloud computing, data management, and virtualization solutions. It delivers enterprise-grade products and services tailored for small to medium-sized businesses, large enterprise clients, and public sector entities, focusing on optimizing IT infrastructure efficiency and cutting operational costs for end users.

Roivant Sciences Ltd. is an American multinational healthcare company focused on applying technology to drug development and building subsidiary life sciences and health technology companies. It was founded in 2014 by Vivek Ramaswamy and is currently headed by CEO Matt Gline. Roivant maintains its headquarters in New York City as well as major offices in the biotech hubs of Boston and Basel.

ANY vs ROIV — Head-to-Head

Bigger by revenue
ANY
ANY
1.4× larger
ANY
$2.7M
$2.0M
ROIV
Growing faster (revenue YoY)
ANY
ANY
+80.9% gap
ANY
3.1%
-77.8%
ROIV
More free cash flow
ANY
ANY
$177.8M more FCF
ANY
$-23.6M
$-201.4M
ROIV
Faster 2-yr revenue CAGR
ANY
ANY
Annualised
ANY
-37.4%
-73.7%
ROIV

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
ANY
ANY
ROIV
ROIV
Revenue
$2.7M
$2.0M
Net Profit
$-265.9M
Gross Margin
Operating Margin
-372.7%
-16966.1%
Net Margin
-13301.2%
Revenue YoY
3.1%
-77.8%
Net Profit YoY
-257.0%
EPS (diluted)
$-6.96
$-0.38

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ANY
ANY
ROIV
ROIV
Q4 25
$2.7M
$2.0M
Q3 25
$2.6M
$1.6M
Q2 25
$3.0M
$2.2M
Q1 25
$2.8M
$-39.6M
Q4 24
$2.6M
$9.0M
Q3 24
$2.4M
$4.5M
Q2 24
$4.7M
$8.0M
Q1 24
$6.9M
$28.9M
Net Profit
ANY
ANY
ROIV
ROIV
Q4 25
$-265.9M
Q3 25
$-4.2M
$-113.5M
Q2 25
$1.7M
$-223.4M
Q1 25
$-8.8M
$-206.5M
Q4 24
$169.4M
Q3 24
$104.0K
$-230.2M
Q2 24
$2.1M
$95.3M
Q1 24
$-4.5M
$-151.1M
Gross Margin
ANY
ANY
ROIV
ROIV
Q4 25
Q3 25
25.4%
Q2 25
23.8%
Q1 25
22.1%
Q4 24
Q3 24
-16.0%
Q2 24
15.2%
Q1 24
38.0%
Operating Margin
ANY
ANY
ROIV
ROIV
Q4 25
-372.7%
-16966.1%
Q3 25
-153.8%
-19492.9%
Q2 25
-87.0%
-13130.0%
Q1 25
-184.2%
674.8%
Q4 24
-328.7%
-3042.6%
Q3 24
-218.8%
-7636.0%
Q2 24
-122.4%
-1279.5%
Q1 24
-26.9%
-919.5%
Net Margin
ANY
ANY
ROIV
ROIV
Q4 25
-13301.2%
Q3 25
-162.0%
-7225.9%
Q2 25
55.2%
-10292.9%
Q1 25
-311.9%
521.8%
Q4 24
1878.3%
Q3 24
4.4%
-5143.8%
Q2 24
45.5%
1192.7%
Q1 24
-64.5%
-522.3%
EPS (diluted)
ANY
ANY
ROIV
ROIV
Q4 25
$-6.96
$-0.38
Q3 25
$-0.15
$-0.17
Q2 25
$0.06
$-0.33
Q1 25
$-0.32
$-0.28
Q4 24
$-4.62
$0.23
Q3 24
$0.01
$-0.31
Q2 24
$0.10
$0.12
Q1 24
$-0.27
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ANY
ANY
ROIV
ROIV
Cash + ST InvestmentsLiquidity on hand
$3.7M
$4.5B
Total DebtLower is stronger
Stockholders' EquityBook value
$23.3M
$4.3B
Total Assets
$25.1M
$5.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ANY
ANY
ROIV
ROIV
Q4 25
$3.7M
$4.5B
Q3 25
$5.3M
$4.4B
Q2 25
$4.7M
$4.5B
Q1 25
$2.8M
$4.9B
Q4 24
$5.4M
$5.1B
Q3 24
$5.0M
$5.4B
Q2 24
$4.3M
$5.7B
Q1 24
$9.3M
$6.5B
Total Debt
ANY
ANY
ROIV
ROIV
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
$311.7M
Q1 24
$430.6M
Stockholders' Equity
ANY
ANY
ROIV
ROIV
Q4 25
$23.3M
$4.3B
Q3 25
$29.5M
$4.4B
Q2 25
$32.7M
$4.3B
Q1 25
$30.7M
$4.7B
Q4 24
$39.3M
$5.2B
Q3 24
$35.8M
$5.2B
Q2 24
$33.4M
$5.4B
Q1 24
$27.5M
$6.0B
Total Assets
ANY
ANY
ROIV
ROIV
Q4 25
$25.1M
$5.2B
Q3 25
$31.1M
$5.1B
Q2 25
$34.4M
$5.0B
Q1 25
$34.3M
$5.4B
Q4 24
$43.2M
$5.8B
Q3 24
$44.3M
$6.2B
Q2 24
$44.0M
$6.5B
Q1 24
$42.0M
$7.2B
Debt / Equity
ANY
ANY
ROIV
ROIV
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
0.06×
Q1 24
0.07×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ANY
ANY
ROIV
ROIV
Operating Cash FlowLast quarter
$-16.1M
$-196.5M
Free Cash FlowOCF − Capex
$-23.6M
$-201.4M
FCF MarginFCF / Revenue
-867.3%
-10076.0%
Capex IntensityCapex / Revenue
275.4%
246.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-40.5M
$-776.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ANY
ANY
ROIV
ROIV
Q4 25
$-16.1M
$-196.5M
Q3 25
$-3.5M
$-185.7M
Q2 25
$-5.8M
$-204.4M
Q1 25
$-4.1M
$-172.6M
Q4 24
$-4.6M
$-207.3M
Q3 24
$290.0K
$-266.8M
Q2 24
$-3.3M
$-192.8M
Q1 24
$-58.0K
$-108.5M
Free Cash Flow
ANY
ANY
ROIV
ROIV
Q4 25
$-23.6M
$-201.4M
Q3 25
$-5.7M
$-193.5M
Q2 25
$-6.0M
$-208.4M
Q1 25
$-5.1M
$-173.4M
Q4 24
$-13.5M
$-209.1M
Q3 24
$-4.3M
$-267.8M
Q2 24
$-193.8M
Q1 24
$-108.8M
FCF Margin
ANY
ANY
ROIV
ROIV
Q4 25
-867.3%
-10076.0%
Q3 25
-218.7%
-12317.8%
Q2 25
-200.5%
-9604.5%
Q1 25
-181.2%
438.1%
Q4 24
-511.9%
-2318.5%
Q3 24
-184.4%
-5984.4%
Q2 24
-2425.5%
Q1 24
-376.1%
Capex Intensity
ANY
ANY
ROIV
ROIV
Q4 25
275.4%
246.9%
Q3 25
86.5%
499.6%
Q2 25
6.6%
185.9%
Q1 25
36.4%
-2.0%
Q4 24
338.7%
20.3%
Q3 24
196.7%
22.3%
Q2 24
0.0%
12.1%
Q1 24
0.0%
1.2%
Cash Conversion
ANY
ANY
ROIV
ROIV
Q4 25
Q3 25
Q2 25
-3.51×
Q1 25
Q4 24
-1.22×
Q3 24
2.79×
Q2 24
-1.55×
-2.02×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons